Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

On International Men's Day, the Clinical Trials Arena team investigates three therapies being investigated in prostate cancer ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

The prostate is a small walnut-shaped gland in men that cancer cells may begin to grow inside of, but it can take years ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

"We’re finding that plant-derived substances may one day be used to support traditional cancer treatment and prevention ...

Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...

Rupert Crowfoot, 57, was diagnosed with prostate cancer last year after a conversation with a friend encouraged him to get a ...

No man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it ...

14, 2024 — Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell ...